InvestorsHub Logo
Followers 21
Posts 1676
Boards Moderated 0
Alias Born 07/09/2005

Re: None

Tuesday, 10/20/2020 7:13:25 AM

Tuesday, October 20, 2020 7:13:25 AM

Post# of 307
Affimed and NKMax America to Study the Combination of AFM24, an EGFR-Targeted Innate Cell Engager, with SNK01 Natural Killer Cell Therapy

https://www.globenewswire.com/news-release/2020/10/20/2110884/0/en/Affimed-and-NKMax-America-to-Study-the-Combination-of-AFM24-an-EGFR-Targeted-Innate-Cell-Engager-with-SNK01-Natural-Killer-Cell-Therapy.html
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AFMD News